SEC Form 3 · accession 0001615774-19-000103
Intec Pharma Ltd. · NTEC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gil Bianco
Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 2, 2019 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001638381
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | — | holding | — | — | — | — | Jul 1, 2020 | Ordinary Shares | 10,751 | — | D |
| Stock Option (right to buy)F3 | $6.00 | holding | — | — | — | — | Apr 21, 2026 | Ordinary Shares | 22,500 | — | D |
| Stock Option (right to buy)F4 | $4.44 | holding | — | — | — | — | Jun 28, 2025 | Ordinary Shares | 20,000 | — | D |
Explanation of responses
- F1The stock option vested and became exercisable in three equal annual installments on July 1, 2011, July 1, 2012 and July 1, 2013.
- F2The exercise price for the stock option to purchase ordinary shares is 48.91 New Israeli Shekels.
- F3The stock option vested and became exercisable as to one-third of the total shares on April 21, 2017 and one-third of the total shares on April 21, 2018. The remaining shares subject to the stock option vest and become exercisable on April 21, 2019.
- F4The stock option vests and becomes exercisable as to one-third of the total shares on June 28, 2019 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through June 28, 2021.
Remarks
The Reporting Person is filing this form in connection with the Issuer's transition from reporting as a foreign private issuer to reporting as a domestic issuer, effective January 1, 2019.